Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints

Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39 trial, which was conducted in collaboration with Seagen Inc. (SGEN) and Astellas Pharma Inc. (ALPMY.PK, ALPMY).

RTTNews | 692 일 전

Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

RTTNews | 738 일 전

Japan Shares May Tick Lower Again On Friday

The Japan stock market on Thursday snapped the six-day winning streak in which it had surged more than 3,000 points or 7.3 percent. The Nikkei 225 now sits just beneath the 42,650-point plateau and it may remain stuck in neutral on Friday.

RTTNews | 24 분 전

New Zealand Manufacturing Sector Expands In July - BusinessNZ

The manufacturing sector in New Zealand moved up into expansion territory in July, BusinessNZ said on Friday with a seasonally adjusted Performance of Manufacturing Index score of 52.8.

RTTNews | 31 분 전

Japan GDP Data Due On Friday

Japan will on Friday release preliminary Q2 numbers for gross domestic product, highlighting a busy day for Asia-Pacific economic activity. GDP is expected to rise 0.1 percent on quarter and 0.4 percent on year following the flat quarterly reading and the 0.2 percent contraction in the three months prior. Capex is seen higher by 0.5 percent on quarter, easing from 1.1 percent in Q1.

RTTNews | 1 시간 24 분 전